Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE
Pfizer Limited
ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE
80 Milligram
Capsules Hard
Product subject to prescription which may not be renewed (A)
Authorised
0000-00-00
1 PACKAGE LEAFLET: INFORMATION FOR THE USER Ziprasidone Pfizer 20 mg, 40 mg, 60 mg, 80 mg capsules, hard ziprasidone READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Ziprasidone Pfizer capsules are and what they are used for 2. Before you use Ziprasidone Pfizer capsules 3. How to take Ziprasidone Pfizer capsules 4. Possible side effects 5. How to store Ziprasidone Pfizer capsules 6. Further information 1. WHAT ZIPRASIDONE PFIZER CAPSULES ARE AND WHAT THEY ARE USED FOR Ziprasidone Pfizer capsules belong to a group of medicines called antipsychotics. Ziprasidone Pfizer capsules are used for the treatment of schizophrenia in adults - a mental disorder characterised by the following symptoms: to hear, see and feel things that do not exist, to believe in something not true, to feel unusual suspicions, to be absent and have difficulty in establishing social relationships, nervousness, depression or anxiety. Ziprasidone Pfizer capsules are also used for the treatment of manic or mixed episodes of moderate severity in bipolar disorder in adults and children and adolescents aged 10-17 years - a mental disorder characterised by alternate stages of euphoric (mania) or depressed mood states. During mania episodes, the most characteristic symptoms are: elated behaviour, exagge Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ziprasidone Pfizer 80mg capsules, hard 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each hard capsule contains ziprasidone hydrochloride monohydrate equivalent to 80 mg of ziprasidone Excipient(s): Each 80 mg capsule contains 175.65 mg lactose monohydrate. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Capsule, hard (Capsule) No 2, blue/white capsules, marked “Pfizer” and ZDX 80 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ziprasidone is indicated for the treatment of schizophrenia in adults. Ziprasidone is indicated for the treatment of manic or mixed episodes of moderate severity in bipolar disorder in adults and children and adolescents aged 10-17 years (prevention of episodes of bipolar disorder has not been established - see section 5.1). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Adults_ The recommended dose, in acute treatment of schizophrenia and bipolar mania, is 40 mg twice daily taken with food. Daily dosage may subsequently be adjusted on the basis of individual clinical status up to a maximum of 80 mg twice daily. If indicated, the maximum recommended dose may be reached as early as day 3 of treatment. _It is of particular importance not to exceed the maximum dose as the safety profile above 160 mg/day has not been_ _confirmed and ziprasidone is associated with dose-related prolongation of the QT interval (see sections 4.3 and 4.4)._ In maintenance treatment of schizophrenia patients, ziprasidone should be administered at the lowest effective dose; in many cases, a dose of 20 mg twice daily may be sufficient. _Elderly_ A lower starting dose is not routinely indicated but should be considered for those 65 and over when clinical factors warrant. _Use in renal im Read the complete document